Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
US Army
Chinese Patent Office
Cipla
US Department of Justice
AstraZeneca
Queensland Health
Fuji

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006188

« Back to Dashboard

NDA 006188 describes PROPYLTHIOURACIL, which is a drug marketed by Abbott, Actavis Elizabeth, Anabolic, Ani Pharms Inc, Chartwell Rx, Dava Pharms Inc, Halsey, Hikma Intl Pharms, Impax Labs, Lannett, Lilly, Sun Pharm Industries, Tablicaps, and Watson Labs, and is included in fifteen NDAs. It is available from seven suppliers. Additional details are available on the PROPYLTHIOURACIL profile page.

The generic ingredient in PROPYLTHIOURACIL is propylthiouracil. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the propylthiouracil profile page.
Summary for 006188
Tradename:PROPYLTHIOURACIL
Applicant:Dava Pharms Inc
Ingredient:propylthiouracil
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 006188
Medical Subject Heading (MeSH) Categories for 006188
Suppliers and Packaging for NDA: 006188
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROPYLTHIOURACIL propylthiouracil TABLET;ORAL 006188 NDA Par Pharmaceutical 67253-651 N 67253-651-10
PROPYLTHIOURACIL propylthiouracil TABLET;ORAL 006188 NDA Par Pharmaceutical 67253-651 N 67253-651-11

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:BDRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Express Scripts
Cerilliant
Medtronic
Merck
Moodys
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.